02/17/2026
According to the AHA, genetic and genomic testing is no longer a niche service in cardiovascular care—it is an essential component of modern diagnosis, risk stratification, and family‑centered management. What’s changed in this latest policy isn’t which patients benefit—but how health care systems are expected to deliver cardiovascular genetics at scale.
Learn more: http://spr.ly/6186hwZwK
Musunuru et al. 2020. PubMed ID: 32698598
Landstrom et al. 2025. 41230602
Our vision: to improve lives through genetic testing—and empower clinicians with insights for their patients. We offer whole genome and exome sequencing, with a team of genetic experts for step-by-step support.